We examined the extent of renal medullary blood flow (MBF) autoregulation in pentobarbital anesthetized rabbits. Two methods for altering renal arterial pressure (RAP) were compared; the conventional method of graded supra-renal aortic occlusion, and an extracorporeal circuit that allows RAP to be increased above systemic arterial pressure. Changes in MBF were estimated by laser Doppler flowmetry, which appears to predominantly reflect red cell velocity, rather than flow per se, in the kidney. We compared responses using a dual fiber needle probe held in place by a micromanipulator, with those from a single fiber probe anchored to the renal capsule, to test whether RAP-induced changes in kidney volume confound medullary laser Doppler flux (MLDF) measurements. MLDF responses were similar for both probe types, and both methods for altering RAP. MLDF changed little as RAP was altered from 50 to at least 170 mmHg (24 ± 22% change).
Introduction
Pressure diuresis/natriuresis is a key mechanism in the long-term control of arterial pressure.
There is now strong evidence that this mechanism is mediated, at least in part, by a direct relationship between renal arterial pressure (RAP) and renal interstitial hydrostatic pressure, which in turn profoundly influences tubular sodium reabsorption (13, 25, 34, 35) . However, there is still much controversy as to the mechanism(s) by which increased RAP increases renal interstitial hydrostatic pressure, since total renal blood flow (RBF) and glomerular filtration rate are well autoregulated. One proposition is that increased RAP increases vasa recta capillary blood flow and pressure, which in turn increases renal interstitial hydrostatic pressure (8) . This hypothesis is supported by observations, particularly in volume expanded rats, of poor autoregulation of medullary blood flow (MBF) (13, 18, 21, 28, 35, 39, 40) . In contrast however, other studies have demonstrated efficient autoregulation of MBF in rats and dogs (6, 9, 17, (23) (24) (25) (26) (27) 29) , even under conditions of volume expansion (24) . These and other observations have led to an alternative hypothesis, that increased RAP increases the renal production of nitric oxide, which in turn mediates the increase in renal interstitial hydrostatic pressure (25) . Thus, the issue of MBF autoregulation remains central to elucidating the precise mechanisms mediating pressure diuresis/natriuresis. Therefore, in this study we used laser Doppler flowmetry to examine the degree of MBF autoregulation in anesthetized rabbits. We paid particular attention to the impact of methodological issues, such as the method used to alter RAP, the method of securing the flow probe for MBF measurements, and the validity of the laser Doppler methodology. Our results indicate that these factors do affect observations of autoregulatory behavior of the renal vasculature. However, regardless of these technical issues, our data suggest that medullary erythrocyte velocity is efficiently autoregulated in anesthetized rabbits, between 50 and at least 170 mmHg. However our data also indicate that the laser Doppler method would not necessarily detect recruitment of vasa recta as RAP is increased, so we cannot exclude the possibility that MBF increases as RAP is increased in this model.
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Methods
General
Experiments were performed on New Zealand White rabbits, except for the supplementary experiments employing isolated, blood perfused kidneys, for which a cross-bred English strain of rabbits was used. The animals were meal fed and were allowed water ad libitum until experimental procedures began. At the conclusion of the experiment the animals were killed with an intravenous overdose of pentobarbital sodium (300mg, Nembutal; Merial Australia Pty Ltd, NSW, Australia). All Two main experimental protocols were performed, as well as supplementary experiments examining the validity of the laser Doppler method. In Protocol 1 we determined the regional renal hemodynamic and renal excretory responses to progressively increasing RAP using an extracorporeal circuit. Once the extracorporeal circuit was established, RAP was increased in steps from 65 to 160 mmHg, while we monitored RBF, cortical and medullary laser Doppler flux (CLDF and MLDF) ( Fig.   1 ), urine flow and sodium excretion. Data regarding RBF, [ 3 H]inulin clearance, sodium excretion, urine flow and plasma renin activity from Protocol 1, but not LDF, have previously been published in a different form (7, 43) .
Protocol 2 investigated the impact of the method used to position the medullary laser Doppler probe, and the method used to alter RAP, on MLDF responses to altered RAP. We compared measurements of MLDF made with a probe held in place with a micromanipulator, with those made using a probe attached to the kidney surface ( Fig. 1) . We first progressively altered RAP between 90
and 10 mmHg using a suprarenal aortic cuff (Protocol 2A), and then across the same range using the extracorporeal circuit (Protocol 2B). RAP was then randomly set to levels of RAP between 20 and volume would have contrasting effects on MLDF measurements from the attached probe compared with the externally fixed probe, because if anything, the tip of the attached probe would move further towards the cortical surface. Thus, even if both methods are associated with some systematic error when kidney volume changes, we predict that errors would arise in opposite directions for the two probe types.
In a supplementary experiment, we examined the behavior of CLDF and MLDF in the isolated, blood perfused kidney under conditions of maximal dilatation, and the impact of changes in hematocrit and renal perfusion on these signals.
Preparative Procedures
Catheters were inserted into the central ear arteries and marginal ear veins under local analgesia (1% lidocaine, Xylocaine; Astra Pharmaceuticals, NSW, Australia). Anesthesia was induced by pentobarbital sodium (90-150 mg plus 30-50 mg/h i.v.) and was followed by endotracheal intubation and artificial ventilation. Throughout the surgery Hartmann's solution (compound sodium lactate; Baxter Healthcare, Toongabbie, NSW, Australia) was infused at a rate of 0.18 ml kg -1 min -1 to replace fluid loss. Esophageal temperature was maintained at 36-38 C (20) . First, a right nephrectomy was performed. The left kidney was then exposed by a retroperitoneal incision, denervated, and placed in a stable cup (20) . The aorta, vena cava and renal artery were isolated and ties were placed around them in preparation for establishing the extracorporeal circuit.
Extracorporeal circuit
This has been described in detail (5, 7, 11, 43 Millwey, Devon, England), which was advanced using a micromanipulator so that its tip lay 8-10 mm below the mid-region of the lateral surface of the kidney (inner medulla) (Fig. 1A) . A standard straight plastic probe (DP2b, diameter 6 mm with 500 m fiber separation; Moor Instruments) was also placed on the dorsal surface of the kidney for measurement of CLDF, and held in place with gauze packing.
RAP was then set at 65 mmHg for a 90 min equilibration period. After equilibration, RAP was set at 65, 85, 110, 130 and 160 mmHg for consecutive 20 min periods (Protocol 1A). Urine volume and sodium excretion were determined as previously described (7, 43) .
In 7 of these rabbits, RAP was re-set to 65 mmHg for 20 min. RAP was then randomly re-set each 60 s within the range from 20 to 220 mmHg for 20 min (Protocol 1B).
Protocol 2: Influence of the method for altering RAP, and the method for measuring MLDF, on observations of MBF autoregulation
General Seven male rabbits were studied (2.3 0.1 kg). After completing the preparative procedures, an inflatable cuff was placed around the aorta rostral to the renal artery. Two laser Doppler probes were inserted into the kidney to measure MLDF (Fig. 1B) . One was a 26 gauge dual fiber needle probe inserted to a depth of 8-10 mm and held in place with a micromanipulator, as for Protocol 1 (externally fixed probe). The other was a single fiber plastic probe (DP10d, 500 m diameter; Moor Instruments) with a circular piece of latex attached 10 mm from its tip. Once the single fiber probe was in place, the latex was bonded to the kidney surface with adhesive (Supa Glue;
Selleys Pty. Ltd., NSW, Australia) (attached probe, Fig. 1B ). The single fiber probe was not attached to a micromanipulator and was free to move with the kidney surface. The rabbit was then heparinized (15,000 IU) and the aortic and vena caval limbs of the circuit were established, but the peristaltic pump was not engaged. RAP was determined from a side arm of the aortic catheter, and a transit-time ultrasound flow probe (type 2SB; Transonic Systems Inc.) was placed around the left renal artery for the measurement of RBF. Arterial blood samples (0.5 ml) were collected before and after each of the 3 steps in this protocol, for determination of hematocrit.
Protocol 2A: Progressive changes in RAP using the supra-renal aortic cuff
The inflatable cuff around the aorta was gradually inflated using a micrometer-driven syringe, to reduce RAP in 10 mmHg steps from 90 to 10 mmHg (3 min at each level of RAP). The cuff was then gradually deflated to increase RAP to 90 mmHg, again in 10 mmHg steps each 3 min. dextran perfusion was less than 10 min, after which blood perfusion commenced. Blood (37 C) was re-circulated by collecting the renal venous and ureteric effluent from under the kidney, and feeding it by gravity to a beaker in which the blood was continuously stirred and exposed to 100% O 2 . The peristaltic pump was set to perfuse the kidney at 0, 8, 16, 31, 59 , and 89 ml/min, and then progressively reduce flow by the same steps (3 min at each flow rate). The blood was then diluted two-fold with polygeline/electrolyte solution (Haemaccel) containing the same cocktail of pharmacological agents as the blood itself, and the step changes in renal perfusion were repeated with hematocrit set at approximately 20%. The blood was then diluted to hematocrits of approximately 10% and 5% while the kidney was perfused at 31 ml/min.
Haemodynamic variables
Arterial pressure was measured with pressure transducers (Cobe, Arvada, CO, USA) placed at the level of the rabbit's heart. Systemic arterial pressure (MAP, mmHg) was measured via the ear artery catheters, while RAP (mmHg) was measured via the side arm catheters of the extracorporeal circuit. Heart rate (HR, beats/min) was measured by a tachometer activated by the ear artery pressure pulse. Transit-time ultrasound flow probes were connected to a compatible flowmeter (Transonic Systems Inc., T108) to provide RBF (ml/min), while the laser Doppler flow probes were These data were subjected to model 2 regression analysis (22), to quantify the relationships between changes in RBF with those in CLDF and MLDF.
Protocol 2:
Mean values of RBF, MLDF, 'concentration' and RAP were determined during the last 30 s at each level of RAP, and normalized to levels when RAP was 90 mmHg (A and B) or 20 mmHg (C). Analysis of variance was performed, using combinations of the factors rabbit, RAP, method (extracorporeal circuit or supra-renal aortic cuff) and probe (RBF, externally fixed, and attached medullary probes). Specific contrasts were then made by 'method' and 'probe'.
Isolated kidney experiments:
Model 1 regression analysis (22) was used to relate the independent variables (pump flow rate and hematocrit) to RBF determined by transit-time ultrasound flowmetry, and flux and concentration signals from the cortex and medulla.
Results
Protocol 1: RBF, CBF and MBF autoregulation in the extracorporeal circuit preparation
Protocol 1A When RAP was increased from 65 to 160 mmHg, progressive increases in urine flow, sodium excretion, RBF and CLDF were observed (Fig. 2) . Modest autoregulation of RBF was observed as RAP was increased to ~110 and ~130 mmHg as evidenced by increases in RVR of 12 ± 4 and 14 ± 5% respectively. Apparent autoregulation of superficial CBF (as reflected by the CLDF signal) was also observed, in this case up to 160 mmHg. Nominal CVR increased progressively as RAP was increased, to be 57 ± 10% greater at 160 than 65 mmHg. MLDF, in contrast to RBF and CLDF, actually fell at higher levels of RAP, so that MLDF was 27 ± 4% less, and nominal MVR 246 ± 23% greater when RAP was 160 mmHg than when it was 65 mmHg.
Protocol 1B Changes in RBF and MLDF were not correlated (r = 0.06, P = 0.49). In contrast, changes in CLDF were highly correlated with changes in RBF (r = 0.92, P < 0.001), although the slope of the relationship was <1, ranging from 0.43 to 0.84 in the 7 rabbits studied (Fig. 3) . The mean slope of the full data set was 0.62 ± 0.02.
Protocol 2(A & B): Influence of the method for altering RAP, and the method for measuring MLDF, on observations of MBF autoregulation Baseline hemodynamic variables
These were similar to those we have observed previously (7, 20, 43) ( Table 1) . In Protocol 2A, MAP measured from the ear artery was 18 ± 3 mmHg less than RAP measured from the descending aorta, presumably reflecting the greater upstream vascular resistance in the ear artery. There were no statistically significant differences in MAP, HR, RBF, or MLDF and 'concentration' measured by either laser Doppler flow probe, between the two steps in the protocol.
As expected however, hematocrit was reduced by 12 ± 1% once the extracorporeal circuit was established. Baseline RAP was also slightly (3 ± 1 mmHg) different in the two steps of the protocol.
Effects of the method for altering RAP on autoregulation of RBF RBF remained stable when RAP
was reduced from 90 to 60 mmHg by inflating a suprarenal aortic cuff, reflecting a 20 ± 6% decrease in RVR. In contrast, when RAP was reduced across the same range using the extracorporeal circuit, RBF fell progressively and RVR did not change (-3 ± 8% change) (Fig. 4) . With both methods, as RAP was further reduced to 20 mmHg, RBF fell progressively and RVR increased to average 133 ± 11% of its baseline level. Reducing RAP to 10 mmHg was accompanied by further vasoconstriction, with RVR increasing to 281 ± 37% of its baseline level. A similar pattern of changes was observed when RAP was progressively increased to 90 mmHg, except that the final levels of RBF and RVR were 36 ± 3% less and 57 ± 6% greater, respectively, than their control levels.
Effects of the method for altering RAP on autoregulation of MBF MLDF remained relatively stable
when RAP was reduced from 90 to 50 mmHg, reflecting a 43 ± 5% decrease in nominal MVR (Fig.   5 ). As RAP was further reduced to 10 mmHg, MLDF fell, at the same time nominal MVR decreased to 35 ± 7% of resting levels. A similar pattern of changes was observed when RAP was progressively increased to 90 mmHg. The patterns of changes in MLDF were similar for the two methods of altering RAP (Fig. 5 ). There were, however, quantitative differences in these responses. For example, MLDF fell slightly more, and nominal MVR fell slightly less, when RAP was reduced using the extracorporeal circuit than when the suprarenal aortic cuff was used. MLDF also increased less and nominal MVR increased more, when RAP was increased from 10 to 90 mmHg using the extracorporeal circuit compared with the supra-renal aortic cuff. 
Comparison of RBF and MLDF
Comparison of methods for measuring MLDF
When RAP was reduced from 90 to 70 mmHg using the aortic cuff, MLDF remained relatively constant, regardless of the probe providing the measurement (Fig. 5) . As RAP was further reduced to 50 mmHg, MLDF measured by the externally fixed probe increased by 24 ± 9%, whereas MLDF measured by the attached probe did not change significantly (+6 ± 7% change) (P PROBE 0.001). As RAP was further reduced to 10 mmHg, similar progressive decreases in MLDF were observed with both probes. Although the overall pattern of responses of nominal MVR were similar with the two probes, there were quantitative differences, in that nominal MVR estimated from the externally fixed probe fell slightly more as RAP was reduced than did nominal MVR estimated from the attached probe (Fig. 5 ). Similar observations were made when RAP was altered using the extracorporeal circuit ( Fig 5) (P PROBE < 0.001).
'Concentration'
The 'concentration' signal measured by the externally fixed probe was always greater than that measured by the attached probe. However, they both remained relatively stable across a wide range of RAP, and only began to fall once RAP was reduced beyond 40-50 mmHg.
Similar patterns of responses of this variable were seen, regardless of the method used for altering RAP (data not shown).
Protocol 2C: Random changes of RAP to set levels using the extracorporeal circuit
Between 20 and 80 mmHg, and also between 110 and 170 mmHg, RBF was linearly related to RAP. However, RBF remained relatively stable as RAP was altered between 80 mmHg (26 ± 2 ml/min) and 110 mmHg (30 ± 2 ml/min). In contrast to RBF, MLDF was linearly related to RAP only below 50 mmHg. Thus, MLDF remained relatively stable as RAP was altered between 50 mmHg (93 ± 9 units) and 170 mmHg (118 ± 20 units). The profiles of changes in MLDF were similar for the two medullary probes (Fig. 6) . The 'concentration' signals also remained relatively stable at levels of RAP greater than 50 mmHg, but reduced progressively from 134 ± 14 units (at RAP = 50 mmHg) to 102 ± 13 units as RAP was reduced to 20 mmHg (Fig. 6 ).
Supplementary experiment: isolated, maximally dilated, blood perfused kidney
When hematocrit was ~40%, RBF measured by an in-line transit-time ultrasound flow probe, CLDF and MLDF were all highly correlated with the perfusion rate set by the peristaltic pump. The relationships were little affected when hematocrit was reduced to ~20% (Fig. 7) . When these data were normalized to the values observed when the peristaltic pump was set to deliver 31 ml/min, the slopes of the relationships for RBF, CLDF and MLDF were (mean(95% confidence intervals)): flowprobe seems to slightly over-estimate changes in RBF. If we assume that in this passive system flow changes similarly in all kidney regions, then it seems likely that MLDF slightly underestimates changes in MBF, while CLDF grossly under-estimates changes in CBF.
The 'concentration' signals from the cortex and medulla were not greatly affected by the perfusion rate set by the peristaltic pump (data not shown) or hematocrit (Fig. 8) .
Discussion
Previous studies investigating the efficiency of MBF autoregulation in anesthetized rats and dogs using laser Doppler flowmetry have provided disparate results (6, 9, 13, 17, 18, 21, 23-29, 35, 38-40). Here we examined this issue in anesthetized rabbits, and addressed a number of methodological issues that might confound studies of MBF autoregulation. Our major finding was that MLDF, which appears to chiefly reflect erythrocyte velocity within the medulla, remained remarkably constant within the RAP range from 50 to at least 170 mmHg. We have considerable confidence in the validity of our findings, since they were little influenced by the method used to alter RAP, the type of laser Doppler probe (dual or single fiber), or the method of securing the medullary laser Doppler probe. Our observations therefore indicate that if MBF does increase with increasing RAP in this model, this is likely to be exclusively mediated by recruitment of vasa recta.
The results of Protocol 1 suggested to us that MBF was remarkably well autoregulated between 65 and 160 mmHg, but we had three technical concerns regarding these observations. The first related to the validity of laser Doppler flowmetry, and the identification of its limitations under our experimental conditions. Our second concern related to the extracorporeal circuit preparation, which differs from conventional methods for studying renal autoregulatory behaviour (graded aortic or renal arterial occlusion). Our third concern related to the impact of changes in kidney volume on MLDF measurements. We reasoned that kidney volume might increase with increasing RAP. Since our medullary needle probe was held in place by a micromanipulator, increases in kidney volume could cause the probe tip to move further towards the papilla, and so into areas of lower perfusion (21, 31) .
Strengths and limitations of laser Doppler flowmetry for estimating regional kidney blood flow
Our results reveal limitations of the laser Doppler method when used in the kidney. Firstly, although LDF correlates well with erythrocyte velocity, it is relatively insensitive to changes in erythrocyte concentration in highly perfused tissues such as the kidney (1, 36). For example, the 'concentration' signal changed little in the isolated, blood perfused (and maximally dilated) kidney, when hematocrit was progressively reduced from ~40 to ~5%. Furthermore, the gains of the relationships between RBF and LDF in the medulla and cortex were not affected when hematocrit was reduced from ~40% to ~20%. Previous studies in rats have provided evidence that vasa recta recruitment can contribute to RAP-dependent changes in MBF. Another limitation of the laser Doppler method is that in vivo, changes in erythrocyte velocity estimated by LDF may underestimate true changes. Thus, in Protocol 1 we found that a doubling of RBF was associated with an increase in CLDF of only about 60%. This was not due to regional differences in autoregulation of blood flow within the cortex, since a similar relationship was observed in the isolated, blood perfused and maximally dilated kidney. This is not an instrument error, since we have previously established that a doubling of erythrocyte velocity in polyvinylchloride tubing (at least between 0 and 4 mm/s) is associated with a doubling of LDF (see Methods and (16)).
It is also unlikely to be due to differences in the gain of individual flow probes or probe types, since these were normalized using a motility standard before use. Furthermore, we have previously shown a slope of unity for the relationship between relative changes in CLDF measured by the DP4s (needle) and DP2b (standard) probes used in this study, in response to renal arterial infusions of a vasoconstrictor (19) . Nevertheless, this seems to be a less serious problem for MBF (than CBF), since the slope of the MLDF/RBF relationship in the isolated kidney was only slightly less than unity. We can also be confident that we can detect increases in MBF with the techniques used herein, since we have previously detected increases in CLDF and MLDF in response to vasodilators such as acetylcholine and bradykinin (30, 33) , and increases in MLDF in response to angiotensin II and endothelin-1, both in a standard anesthetized rabbit preparation and in the extracorporeal circuit preparation (10-12). For example in our standard rabbit preparation, a bolus of bradykinin into the renal artery has been shown to increase MLDF by ~100% from a baseline of ~100 units. At the same time, CLDF increased by ~20% from a baseline value of ~380 units (30) . The largest increase in MLDF that we have detected has been in response to endothelin -1 which, when given as a bolus into the renal artery, increased MLDF from a baseline of ~100 units to ~270 units (30) .
Methods for changing RAP
An advantage of the extracorporeal circuit, over conventional methods for altering RAP, is that RAP can be increased to levels greater than MAP. For example, despite ligation of the terminal abdominal aorta in the present study, the maximum level of RAP we could study using the suprarenal aortic cuff method was only ~90 mmHg. In contrast, RAP could be increased to at least 170 mmHg with the extracorporeal circuit. As a result, we could study the behaviour of regional kidney blood flow across a wider range of RAP than any previous study we are aware of. However, there are a number of other differences between this approach and the conventional suprarenal aortic cuff method. For example, RBF was more efficiently autoregulated within the range from 60-90 mmHg with the suprarenal aortic cuff than with the extracorporeal circuit. However, RBF was efficiently autoregulated between 80 and 110 mmHg when RAP was altered using the extracorporeal circuit. Collectively, these data indicate that the lower end of the autoregulatory range of RBF is at a greater level of RAP under the conditions of the extracorporeal circuit. Because we could not study levels of RAP greater than 90 mmHg using the supra-renal aortic cuff, we are unable to determine The method used for changing RAP had small but statistically significant effects on the profiles of changes in MLDF. MLDF measured by the attached probe fell slightly (by 16 ± 7%) as RAP was reduced from 90 to 50 mmHg using the extracorporeal circuit, but not when the supra-renal aortic cuff was used (3 ± 6% change). However, the overall pattern of responses was similar for both methods. When RAP was altered using the extracorporeal circuit, MLDF remained remarkably stable between 50 and 170 mmHg. Thus, medullary erythrocyte velocity appears to be more efficiently autoregulated than total RBF. The results of Protocol 1 indicate that medullary erythrocyte velocity is also more efficiently autoregulated than superficial cortical erythrocyte velocity, an observation consistent with previous findings of Nafz et al in anesthetized rats (29). These conclusions are not invalidated by our finding that changes in CLDF, and to a lesser extent MLDF, may underestimate changes in erythrocyte velocity in these vascular territories, since the differences in the responses to changes in RAP of RBF and CLDF on the one hand, and MLDF on the other, were far greater than the estimated bias of these measurements.
Impact of RAP-dependent changes in kidney volume on LDF estimates of MBF
We reasoned that decreases in kidney volume might cause the needle probe held by a micromanipulator to measure erythrocyte velocity in tissue closer to the kidney surface, where blood flow could be greater. With the attached probe, decreases in kidney size might result in the probe moving further into the medulla, and so to areas of relatively lower flow. Thus, while both methods might be associated with some error, together they should at least define the limits of this error.
However, the overall pattern of responses of MLDF to altered RAP was similar for the two methods.
We therefore conclude that the laser Doppler method for estimating MBF is relatively robust to changes in kidney volume induced by alterations in RAP.
However there were increases in MLDF measured using the externally fixed probe when RAP was reduced from 90-50 mmHg, that were not observed with the attached probe (Protocols 2A & B) .
As a result, the apparent lower point of the autoregulatory range of medullary erythrocyte velocity was 50 mmHg for the attached probe, but 30 mmHg for the externally fixed probe. According to the argument presented in the previous paragraph, the true lower point of autoregulation of medullary erythrocyte velocity should lie within this range. Changes in kidney volume might also explain the small reductions in MLDF observed when RAP was increased in Protocol 1, in which an externally fixed probe was used. The tip of the probe may have moved slightly further into the medulla, towards areas of relatively lower flow, as RAP was increased. Interestingly, there was no reduction in MLDF at the higher levels of RAP when MLDF was measured using the externally fixed probe in Protocol 2C, nor when RAP was increased during Protocols 2A & B. Differences in experimental conditions such as the activity of the renin/angiotensin system, and the duration and order of presentation of each level of RAP, may have contributed to the these apparent differences between our observations in the various experimental protocols.
Conclusions
Our results indicate that certain technical issues must be considered when laser Doppler flowmetry is used in studies of regional kidney blood flow autoregulation. Firstly, changes in LDF in the kidney, under our experimental conditions, chiefly reflect changes in erythrocyte velocity rather than blood flow per se. This, and other factors, may lead to changes in LDF under-estimating true changes in local blood flow when RAP is altered. Secondly, our results indicate that the autoregulatory range of RBF is reduced when studied using an extracorporeal circuit preparation relative to conventional techniques. Nevertheless, the extracorporeal circuit approach does have the advantage that autoregulatory behaviour can be studied over a wider range of RAP. Thirdly, our results indicate that changes in kidney volume can potentially confound measurements of MLDF under conditions where RAP is changing. However, the magnitude of this confounding effect is small, and can be quantified if MLDF is monitored by both methods described herein. Importantly, the characterization of these methodological limitations in the present study, has allowed us to conclude with considerable confidence that medullary red cell velocity is more efficiently autoregulated than total RBF or superficial cortical red cell velocity in the rabbit kidney, at least within the RAP range from 50 -170 mmHg. In the rabbits studied in Protocol 1, fractional sodium excretion increased from less than 10% to more than 40% as RAP was increased from 65 to 160 mmHg (7, 43 ), yet MLDF did not increase. Our present observations therefore indicate that pressure diuresis/natriuresis in this model can proceed in the absence of changes in medullary erythrocyte velocity. However as with exclude the possibility that in our model, MBF increases in response to increased RAP due to vasa recta recruitment.
Perspectives
The renal medulla normally operates on the brink of hypoxia (4). Our present results are consistent with the notion that MBF is more efficiently autoregulated than CBF in the rabbit kidney. Future studies should test this hypothesis using methods that allow assessment of bulk blood flow, rather than just erythrocyte velocity, in the medulla. From a theoretical basis, efficient autoregulation of MBF could provide a mechanism for protecting the medulla from ischemia during acute reductions in arterial pressure, which might otherwise lead to injury of highly metabolic tubular elements such as the medullary thick ascending limbs of the loop of Henle (4). Note that levels of U Na +V and U VOL are expressed per gram of dry kidney weight. 
